Tamoxifen Unknown Status Phase 2 Trials for Melanoma (Skin) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00492505Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma